Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA.
Exp Neurol. 2010 Apr;222(2):204-10. doi: 10.1016/j.expneurol.2009.12.027. Epub 2010 Jan 4.
Drainage and diversion of cerebrospinal fluid (CSF) through shunt systems is the most common treatment for hydrocephalus, but complications due to tissue obstruction of the catheter occur in up to 61% of patients. Although shunt systems have undergone limited technological advancements to resist mammalian cell adhesion, there is a need to further reduce adhesion that can exacerbate obstruction. The high intrinsic variability in clinical studies and an inability to predict chronic adhesion of host cells in vitro while maintaining the environmental conditions observed in hydrocephalus have impeded progress. We designed the hydrocephalus shunt catheter bioreactor (HSCB) to measure inflammatory cell adhesion under experimentally manipulated conditions of CSF pressure, pulsation rate, and flow rates. For a 20-h period, astrocytes were perfused through the pulsatile flow system, and adhesion on silicone catheters was recorded. These results were compared with those obtained under static cell culture conditions. Astrocyte adhesion was significantly increased under conditions of increased flow rate (0.25 and 0.30 mL/min), and a trend toward increased adhesion was observed under conditions of elevated pressure and pulsation rate. Because the HSCB represents physiologic conditions more accurately than static cell culture, our results suggest that standard static cell culturing techniques are insufficient to model inflammatory cell adhesion on catheters used in the treatment of hydrocephalus and that changes to the ventricular microenvironment can alter the mechanisms of cellular adhesion. The HSCB represents a relevant test system and is an effective model system for the analysis of cellular adhesion and occlusion of shunt catheters.
通过分流系统引流和转移脑脊液(CSF)是治疗脑积水最常见的方法,但由于导管组织阻塞,多达 61%的患者会出现并发症。尽管分流系统已经进行了有限的技术改进以抵抗哺乳动物细胞的黏附,但仍需要进一步减少黏附,以减轻阻塞。由于临床研究中的固有变异性较高,并且无法在体外模拟宿主细胞的慢性黏附,同时保持脑积水观察到的环境条件,因此阻碍了进展。我们设计了脑积水分流导管生物反应器(HSCB),以在 CSF 压力、脉动率和流速等实验操纵条件下测量炎症细胞黏附。在 20 小时的时间内,通过脉动流系统灌流星形胶质细胞,并记录硅酮导管上的黏附。将这些结果与静态细胞培养条件下获得的结果进行比较。在流速增加(0.25 和 0.30 mL/min)的情况下,星形胶质细胞黏附显著增加,在压力和脉动率升高的情况下,黏附有增加的趋势。由于 HSCB 比静态细胞培养更准确地代表生理条件,因此我们的结果表明,标准的静态细胞培养技术不足以模拟用于治疗脑积水的导管上的炎症细胞黏附,并且脑室微环境的变化可以改变细胞黏附的机制。HSCB 代表了一种相关的测试系统,是分析分流导管细胞黏附和阻塞的有效模型系统。